C4 Therapeutics, Inc. · NASDAQ:CCCC
Morgan Stanley's stake in C4 Therapeutics, Inc. fell to 8.00% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 12, 2026
Morgan Stanley's stake in C4 Therapeutics, Inc. fell to 8.00%, 8,862,002 shares, as a passive investor on Jun 30, 2026. Filed Aug 12, 2026 (Schedule 13G/A).
- Stake
- 8.00%
- Shares
- 8,862,002
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 8.00% | 8,862,002 |
| Morgan Stanley Capital Services LLC | 7.90% | 8,718,000 |
| Morgan Stanley & Co. LLC | 0.10% | 134,047 |
Source
Related
- C4 Therapeutics, Inc.
- Morgan Stanley
- C4 Therapeutics, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Feb 11, 2026
- Schedule 13G/A · Morgan Stanley · Aug 7, 2025
- Schedule 13G · Morgan Stanley · Feb 3, 2025
- Form 4 · Anderson Kenneth Carl · Oct 2, 2026
- Form 4 · Grogan Donna Roy · Oct 2, 2026
- Form 4 · Adams Kendra · Sep 21, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026